FR2412568A1 - Dihydroxy-1-alpha, 2-beta oxo-24 cholestadiene-5,7 et ses derives - Google Patents

Dihydroxy-1-alpha, 2-beta oxo-24 cholestadiene-5,7 et ses derives

Info

Publication number
FR2412568A1
FR2412568A1 FR7905553A FR7905553A FR2412568A1 FR 2412568 A1 FR2412568 A1 FR 2412568A1 FR 7905553 A FR7905553 A FR 7905553A FR 7905553 A FR7905553 A FR 7905553A FR 2412568 A1 FR2412568 A1 FR 2412568A1
Authority
FR
France
Prior art keywords
oxo
alpha
cholestadiene
dihydroxy
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7905553A
Other languages
English (en)
Other versions
FR2412568B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of FR2412568A1 publication Critical patent/FR2412568A1/fr
Application granted granted Critical
Publication of FR2412568B1 publication Critical patent/FR2412568B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

LE DIHYDROXY-1-ALPHA, 2-BETA OXO-24 CHOLESTADIENE-5,7 ET SES DERIVES SONT UNE MATIERE PREMIERE UTILE POUR LA PREPARATION DE L'HYDROXY-1 ALPHA OXO-24 VITAMINE D QUI EST UN MEDICAMENT PROVOQUANT LA REGULATION DU METABOLISME DU CALCIUM.
FR7905553A 1977-09-07 1979-03-02 Dihydroxy-1-alpha, 2-beta oxo-24 cholestadiene-5,7 et ses derives Granted FR2412568A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52106677A JPS5822479B2 (ja) 1977-09-07 1977-09-07 １α−ヒドロキシ−２４−オキソ−ビタミンＤ↓３およびその製造法

Publications (2)

Publication Number Publication Date
FR2412568A1 true FR2412568A1 (fr) 1979-07-20
FR2412568B1 FR2412568B1 (fr) 1982-11-26

Family

ID=14439690

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7825774A Granted FR2421882A1 (fr) 1977-09-07 1978-09-07 Hydroxy l'alpha oxo-24 vitamine d3 et son procede de preparation
FR7905553A Granted FR2412568A1 (fr) 1977-09-07 1979-03-02 Dihydroxy-1-alpha, 2-beta oxo-24 cholestadiene-5,7 et ses derives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7825774A Granted FR2421882A1 (fr) 1977-09-07 1978-09-07 Hydroxy l'alpha oxo-24 vitamine d3 et son procede de preparation

Country Status (6)

Country Link
US (1) US4199577A (fr)
JP (1) JPS5822479B2 (fr)
CH (1) CH643827A5 (fr)
DE (1) DE2838092C3 (fr)
FR (2) FR2421882A1 (fr)
GB (1) GB2006216B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1138859A (fr) * 1979-02-15 1983-01-04 Teijin Limited Derives de 25-hydroxy-24-oxocholestane, et leur preparation
US4264513A (en) * 1979-05-21 1981-04-28 Wisconsin Alumni Research Foundation 1α-hydroxy-25-keto-27-nor-cholecalciferol and processes for preparing same
US4336193A (en) * 1980-08-04 1982-06-22 Wisconsin Alumni Research Foundation Process for preparing vitamin D-lactones
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
JPS6067423A (ja) * 1983-09-22 1985-04-17 Teijin Ltd 脱腫瘍剤
JPS60105881U (ja) * 1983-12-24 1985-07-19 渡辺　三郎 コンプレツサ−の排水接続具
US4481198A (en) * 1984-02-13 1984-11-06 Wisconsin Alumni Research Foundation Vitamin D metabolism inhibitor
JPS61113487U (fr) * 1984-12-27 1986-07-17
JPH09304559A (ja) * 1996-05-16 1997-11-28 Casio Comput Co Ltd モジュール構造

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51100055A (en) * 1975-02-27 1976-09-03 Teijin Ltd 244 okisokorekarushifuerooruruino seizoho

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
GB1503942A (en) * 1974-05-24 1978-03-15 Wisconsin Alumni Res Found Calciferol derivatives
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
DE2525981A1 (de) * 1975-06-11 1976-12-23 Thermokolben Glashuette Werner Hohlglasstein als isolierendes bauelement
US4165660A (en) * 1977-09-19 1979-08-28 Bunker Ramo Corporation Alignment pin installation tool

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51100055A (en) * 1975-02-27 1976-09-03 Teijin Ltd 244 okisokorekarushifuerooruruino seizoho

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1977 *

Also Published As

Publication number Publication date
JPS5441856A (en) 1979-04-03
DE2838092C3 (de) 1981-04-30
GB2006216B (en) 1982-09-02
US4199577A (en) 1980-04-22
JPS5822479B2 (ja) 1983-05-09
FR2421882B1 (fr) 1982-10-29
DE2838092B2 (de) 1980-05-22
DE2838092A1 (de) 1979-03-08
CH643827A5 (de) 1984-06-29
FR2412568B1 (fr) 1982-11-26
GB2006216A (en) 1979-05-02
FR2421882A1 (fr) 1979-11-02

Similar Documents

Publication Publication Date Title
BE883100A (fr) Regulateur d'ecoulement implantable, notamment pour l'infusion de medicaments
AU639717B2 (en) 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
IT7927064A0 (it) Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione, medicamento contenente tale composizione eprocedimento per prepararla.
FR2412568A1 (fr) Dihydroxy-1-alpha, 2-beta oxo-24 cholestadiene-5,7 et ses derives
BE847095A (fr) Comprime pour la liberation controlee d'un medicament et sa preparation,
CA1029661A (fr) Forme de n-4-2(5-chloro-2-methoxy-benzamido)-ethyl-phenol-sulphonyl-n'-cyclohexylurea
BE823522A (fr) Composes du type plasminogene et procede d'obtention de tels composes a partir du pulpes placentaires
FR2429783A1 (fr) Nouveaux derives de vitamines d et leur application en therapeutique
FR2324608A1 (fr) Derives de l'hydroxy-4 cyclopentene-2-one-1 utilisables pour la fabrication de medicaments, et preparation de ces substances
FR2367737A1 (fr) Polypeptide, son procede de preparation et medicament le contenant
ES8307230A1 (es) "un procedimiento para la preparacion de oxaprocin calcico".
FR2359857A2 (fr) Polymeres anti-solaires et compositions cosmetiques les contenant
GB1426499A (en) Pharmaceutical composition for treating liver diseases
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
ES478530A1 (es) Procedimiento para la preparacion de nuevos compuestos ana- logos de prostaciclina.
FR2317288A1 (fr) Procede de preparation d'aldehydes polyethyleniques de la serie de la vitamine a et des carotenoides
FR2427331A2 (fr) Derives de l'hydantoine et medicaments contenant ces substances
GB1474749A (en) Pharmaceutical preparations based on cyproterone
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders
JPS535174A (en) Alicyclic derivatives
GB1449043A (en) Treatment of asthma
BE854265A (fr) Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires
JPS51117663A (en) Powdery-substance integer division unit
JPS5344554A (en) 1alpha,2alpha-epoxycholest-5-ene-25-ol-3-one and its preparation
GB1475651A (en) Pharmaceutical composition for the treatment of cancer

Legal Events

Date Code Title Description
ST Notification of lapse